You are using an outdated browser. Please upgrade your browser to improve your experience.

trastuzumab emtansine

Ligand Summary
Immunotoxin that consists of humanized monoclonal anti-HER2 antibody TRASTUZUMAB covalently linked to anti-microtubule agent MAYTANSINOID DM1 for treatment of metastatic breast cancer in patients who previously received trastuzumab and a TAXANES, separately or in combination.
Synonyms & Links
DrugCentral: 4990
LyCHI:  trastuzumab emtansine

Target Activities